[DXCM] DexCom, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 62.51 Change: 0.41 (0.66%)
Ext. hours: Change: 0 (0%)

chart DXCM

Refresh chart

Strongest Trends Summary For DXCM

DXCM is in the medium-term up 26% in 7 months. In the long-term up 115% in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. The company?s ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments, as well as DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that e

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 23.81% Sales Growth - Q/Q-13.64% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-12.04% ROE-15.34% ROI-14.97%
Current Ratio3.95 Quick Ratio3.45 Long Term Debt/Equity0.02 Debt Ratio0.25
Gross Margin67.74% Operating Margin-7.69% Net Profit Margin-8% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.9 M Cash From Investing Activities-25.9 M Cash From Operating Activities3.4 M Gross Profit46.5 M
Net Profit-12.9 M Operating Profit-12.7 M Total Assets189.3 M Total Current Assets146.2 M
Total Current Liabilities37 M Total Debt4.1 M Total Liabilities40.7 M Total Revenue72.8 M
Technical Data
High 52 week156.87 Low 52 week97.52 Last close155.44 Last change0.8%
RSI50.41 Average true range6.12 Beta1.28 Volume568.76 K
Simple moving average 20 days2.74% Simple moving average 50 days6.4% Simple moving average 200 days15.96%
Performance Data
Performance Week7.79% Performance Month1.93% Performance Quart30.85% Performance Half6.81%
Performance Year25% Performance Year-to-date29.75% Volatility daily2.35% Volatility weekly5.26%
Volatility monthly10.78% Volatility yearly37.35% Relative Volume615.21% Average Volume1.07 M
New High New Low

News

2019-11-15 09:38:02 | San Gorgonio Hospital Picks Allscripts Sunrise Community Care

2019-11-14 13:50:12 | Growth Stocks And How To Find Big Stock Market Winners: Try This Blue Dot List In MarketSmith

2019-11-14 13:00:06 | Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

2019-11-14 10:38:35 | 5 Companies Hit 52-Week Highs

2019-11-14 08:08:01 | NextGen's Medfusion Buyout to Improve Patient Experience

2019-11-14 03:19:00 | Dexcom Looks Poised to Build on Its Big Gap Up

2019-11-13 06:04:11 | 5 Relative Price Strength Stocks to Buy for Optimum Returns

2019-11-12 09:30:02 | Is DexCom DXCM Outperforming Other Medical Stocks This Year?

2019-11-12 08:14:01 | The Zacks Analyst Blog Highlights: Dexcom, Fortinet and Agnico Eagle

2019-11-11 10:00:03 | What Makes DexCom DXCM a Strong Momentum Stock: Buy Now?

2019-11-08 09:25:02 | DexCom DXCM Soars to 52-Week High, Time to Cash Out?

2019-11-08 09:11:02 | DexCom DXCM Earnings and Revenues Beat Estimates in Q3

2019-11-08 09:00:00 | Dexcom Announces Upcoming Conference Presentation

2019-11-08 08:14:09 | The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut

2019-11-07 16:39:27 | IBD Stock Of The Day Breaks Out To Record High After Crushing Earnings Views

2019-11-07 13:59:08 | Dow Jones Soars 858 Points In Q4; Why This Market Leader Surpassed An Alternate Buy Point

2019-11-07 02:53:37 | Edited Transcript of DXCM earnings conference call or presentation 6-Nov-19 9:30pm GMT

2019-11-06 16:03:00 | Dexcom Reports Third Quarter 2019 Financial Results

2019-11-01 10:23:02 | DexCom DXCM to Report Q3 Earnings: What's in the Offing?

2019-10-22 04:26:57 | 3 Under the Radar Growth Stocks

2019-10-15 13:25:00 | DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump

2019-10-12 16:56:54 | Here is What Hedge Funds Think About DexCom, Inc. DXCM

2019-10-12 09:55:40 | Is DexCom NASDAQ:DXCM Weighed On By Its Debt Load?

2019-10-10 08:00:21 | Dexcom CEO Kevin Sayer Rallies Employees Around A Noble Mission

2019-10-09 16:47:00 | Dexcom Schedules Third Quarter 2019 Earnings Release and Conference Call for November 6, 2019 at 4:30 p.m. Eastern Time

2019-10-09 10:31:02 | DexCom's DXCM New G6 Pro CGM System Gets FDA Approval

2019-10-08 08:30:00 | Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM

2019-10-07 16:24:46 | Why This High-Ranking Medical Stock Can't Seem To Get Traction

2019-09-27 18:52:10 | Stocks & ETF to Invest in Healthcare Robotics and Innovation

2019-09-23 17:03:09 | Stocks & ETF to Invest in Healthcare Robotics and Innovation

2019-09-20 09:56:01 | CGM Devices Gain Steam, Set New Trend in Diabetes Management

2019-09-17 16:05:00 | Dexcom Promotes Quentin Blackford to Chief Operating Officer

2019-09-17 08:30:00 | Dexcom Appoints Bridgette Heller to Board of Directors

2019-09-13 09:13:01 | IoMT Becomes the Buzzword in New Age MedTech Investing

2019-09-12 23:15:03 | Dexcom Inc DXCM EVP CFO Quentin S. Blackford Sold $1.5 million of Shares

2019-09-11 23:15:01 | Dexcom Inc DXCM President, CEO and Chairman Kevin R Sayer Sold $2.1 million of Shares

2019-09-09 11:05:00 | Dexcom G6® CGM System Now Available In Canada

2019-09-06 09:25:15 | Is DexCom, Inc. NASDAQ:DXCM Expensive For A Reason? A Look At Its Intrinsic Value

2019-09-05 19:15:04 | Dexcom Inc DXCM President, CEO and Chairman Kevin R Sayer Sold $1.7 million of Shares

2019-09-03 14:18:49 | 5 Internet of Things Stocks to Buy Now

2019-09-03 08:50:12 | Here's Why You Should Hold on to DexCom DXCM Stock Now

2019-08-31 07:29:00 | Is Dexcom a Buy?

2019-08-29 08:03:12 | DexCom DXCM Scales 52-Week High: What's Driving the Stock?

2019-08-27 16:22:22 | The 52-Week Highs You Never Heard About

2019-08-23 16:25:00 | Court Rules that the Patents Asserted against Dexcom CGM Systems are Invalid

2019-08-20 06:00:00 | Forget the Inverted Yield Curve, These 3 Stocks Just Hit All-Time Highs

2019-08-19 21:15:32 | Dexcom Inc DXCM President, CEO and Chairman Kevin R Sayer Sold $1.6 million of Shares

2019-08-15 17:09:13 | Edited Transcript of DXCM earnings conference call or presentation 27-Feb-18 9:30pm GMT

2019-08-06 15:09:00 | Why Insulet's Shares Are Rocketing 20.8% Higher Today

2019-08-03 16:05:00 | 5 Top Medical Device Stocks to Buy Now